반응식
[S:1]1[CH:5]=[CH:4][C:3]([CH2:6][CH2:7][CH2:8][C:9]([OH:11])=O)=[CH:2]1.[Cl:12][C:13]1[CH:31]=[CH:30][C:16]2[O:17][C:18]3[CH:29]=[CH:28][CH:27]=[CH:26][C:19]=3[CH2:20][N:21]([C:22]([NH:24][NH2:25])=[O:23])[C:15]=2[CH:14]=1>>[O:11]=[C:9]([NH:25][NH:24][C:22]([N:21]1[CH2:20][C:19]2[CH:26]=[CH:27][CH:28]=[CH:29][C:18]=2[O:17][C:16]2[CH:30]=[CH:31][C:13]([Cl:12])=[CH:14][C:15]1=2)=[O:23])[CH2:8][CH2:7][CH2:6][C:3]1[CH:4]=[CH:5][S:1][CH:2]=1참가 물질
3
실험 절차
8-chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 2-[1-oxo-4-(3-thienyl)butyl]hydrazide (33) was prepared in the manner described in Example 7 on a 5.2 mmol scale from 3-thiophenebutanoic acid (32), prepared as described above in Example 32, and 8-chlorodibenz[b,f][1,4]oxazepine-10(11H)carboxylic acid, hydrazide (1), prepared as described above in Example 1, to yield 0.87 g (37%) product. Analysis calculated for C22H20N3O3SCl (M.W. 441.94): C, 59.79; H, 4.56; N, 9.51; Cl, 8.02. Found: C, 59.76; H, 4.58; N, 9.54; Cl, 8.06; S, 7.25.
후처리
- customprepared
- customprepared
출처 및 근거
- ORD 기록
- ord-20213def41c24147a3c4380c01b32e2e
- 출처 데이터셋
- uspto-grants-1995_11
- 특허 번호
- US05464830
연결된 노트
불러오는 중…